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h Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung, TaiwanBackground: Methylation levels of long interspersed nucleotide elements (LINE-1) are representative of genome-wide
methylation status and play a crucial role in maintaining genomic stability and gene expression. Its prognostic impact on
colorectal cancer (CRC) patients has not been well established. We aim to evaluate the association between LINE-1
methylation status and postoperative oncological outcome in stage III colorectal cancer patients.
Materials and Methods: Between Jan, 2008 and July, 2012, a total of 129 stage III CRC patients following radical resection
and FOLFOX chemotherapy were enrolled for the present study. Global methylation was estimated by analyzing tumor LINE-
1 methylation status using bisulfite-polymerase chain reaction (PCR) and pyrosequencing. Clinical information including
demographics, clinicopathological data, and postoperative outcomes were recorded by trained abstractors. Outcome
measurement included postoperative recurrence and cancer-specific mortality. Univariate and multivariate analysis were
conducted for recognizing prognostic factors of oncological outcome.
Results: The tumor LINE-1 methylation level of 129 cases distributed normally and ranged from 37.4 to 77.9 of 0-100 scale
(mean 63.3; median 63.7, standard deviation 7.1). In the univariate analysis, LINE-1 hypomethylation was more common in
those who aged above and of 65 years and the patients with postoperative recurrence (both p<0.05). Prognostic impact of
LINE-1 hypomethylation on cancer-specific survival was not observed (pZ0.164). In the multivariate analysis, lower LINE-12214-0247/$36 Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier Taiwan LLC. All rights reserved.
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Abstract 123methylation level demonstrated to be the independent risk factors of postoperative recurrence. With introducing a cutoff
value of 70.15%, Kaplan-Meier analysis depicted the low methylation group had more recurrences with shorter disease free
survival (Log rank test, pZ0.010), and those with lower LINE-1 methylation level had a higher adjusted risk of postoperative
recurrence (adjusted OR Z 8.118, 95% CI Z1.190-55.369).
Conclusion: Stage III CRC patients following radical resection and FOLFOX chemotherapy with LINE-1 hypomethylation
status showed a significantly increased risk for more postoperative recurrence and shorter disease-free survival.
